$FCHS Balance Sheet | Understand Stock

$FCHS

$0.01 +$0.00 (0.0%) Close

$FCHS Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Financial Statements

Income Statement Balance Sheet Cashflow Statement

Consolidated Balance Sheets

In millions of USD, except per-share amounts

	Q2 FY2026 As of Jun 30, 2026	Q1 FY2026 As of Mar 31, 2026	Q4 FY2025 As of Dec 31, 2025	Q3 FY2025 As of Sep 30, 2025	Q2 FY2025 As of Jun 30, 2025	Q1 FY2025 As of Mar 31, 2025	Q4 FY2024 As of Dec 31, 2024	Q3 FY2024 As of Sep 30, 2024	Q2 FY2024 As of Jun 30, 2024	Q1 FY2024 As of Mar 31, 2024	Q4 FY2023 As of Dec 31, 2023	Q3 FY2018 As of Sep 30, 2018	Q2 FY2018 As of Jun 30, 2018	Q1 FY2018 As of Mar 31, 2018	Q3 FY2017 As of Sep 30, 2017	Q2 FY2017 As of Jun 30, 2017	Q1 FY2017 As of Mar 31, 2017	Q3 FY2016 As of Sep 30, 2016	Q2 FY2016 As of Jun 30, 2016	Q1 FY2016 As of Mar 31, 2016
ASSETS
Current assets:
Cash and cash equivalents
Cash -restricted (amounts related to VIE of $6,522,191)
Other Current Assets
Employee loans (amounts related to VIE of $856,828 and $652,125)
Prepaid and other current assets
Capitalized financing costs, current portion (amounts related to VIE of $-0- and $1,317)
Total current assets

Property, plant and equipment, net
Goodwill (amount relating to VIE of $899,465)
Deferred costs, net of amortization of $457,079 and $215,096
Patient list, net of accumulated amortization of $90,000 and $75,000
Patents, net of accumulated amortization of $52,525 and $38,200
Investments (amounts related to VIE of $22,005 and $16,914)
Deferred Tax Asset
Deposits
Total other assets
Operating lease right-of-use assets
Deferred tax asset
Deposits
Other Current Assets
Total other assets
Total assets
LIABILITIES AND STOCKHOLDERS’ DEFICIT
Current liabilities:
Accounts payable and accrued expenses
Accounts payable, related party (amount related to VIE of $0 and $251,588)
Stock-based payable
Advances
Operating lease liabilities, current portion
Tax payable
Settlement payable, due to non-controlling interest (amount related to VIE of $6,521,655)
Line of credit, short term (amount related to VIE of $440,024)
Note payable, related party, current portion (amount related to VIE of $-0- and $428,645)
Notes payable
Unearned revenue
Deferred rent, short term portion (amount related to VIE of $0 and $45,203)
Total current liabilities

Deposits held
Line of credit, long term
Notes payable and capital leases, long term portion (amount related to VIE of $83,248 and $0)
Deferred rent
Total long term debt
PPP loan payable
Operating lease liabilities, non-current portion
Total long-term liabilities
Total liabilities
Temporary equity-2022 Put Option
Redeemable common stock (Note 6)
Redeemable Common Stock-2022 Put Option (Note 6)
Stockholders’ deficit:
Preferred stock value
Series A Preferred Stock
Series A Convertible Preferred Stock
Series B Convertible Preferred Stock
Series C Preferred Stock
Series E Preferred Stock
Total preferred stock value
Common stock, $0.001 par value, 100,000,000 shares authorized 32,958,288 and 32,958,288 shares issued and outstanding at June 30, 2026 and December 31, 2025, respectively
Common stock subscription
Additional paid-in capital
Treasury stock, 74,453 common shares, at cost
Accumulated deficit
Total stockholders’ deficit
Non-controlling interest (note 10)
Total equity

Total liabilities and stockholders’ deficit

Comments